29 November 2023
 
Benchmark Holdings plc
("Benchmark" or the "Company")

Directorate Change

The Company is pleased to announce the appointment of Jonathan Esfandi as
Non-Executive Director. Mr Esfandi is the founder and managing partner at JNE
Partners LLP. 

Mr. Esfandi will act as shareholder representative of JNE Partners LLP, a
significant shareholder of the Company, and therefore the Board has concluded
that he is not an independent director. 

Laura Lavers, who joined the Board in November 2022, will retire from the Board
as a Non-Executive Director with effect from today.
 
Peter George, Chairman, commented:
"We welcome Jonathan to the Board and look forward to working together. On
behalf of the Board, I wish to thank Laura Lavers for her contribution over the
past year."

The following information is disclosed in accordance with Rule 17 and paragraph
(g) of Schedule 2 of the AIM Rules for Companies in connection with the
appointment of Jonathan to the Board of the Company:

Full Name: Jonathan Esfandi
Age: 49
Current Directorships: 
JNE PARTNERS LLP
JNE PARTNERS (UK) SERVICES LTD
Former Directorships (previous five years): None within the past five years
Beneficial interest in the equity securities of Benchmark Holdings plc: No
direct beneficial interest. Funds managed by JNE Partners LLP have a holding of
169,263,811 shares in Benchmark 
There is no further information required to be disclosed under Rule 17 or
paragraph (g) of Schedule 2 of the AIM Rules for Companies.

Enquiries
For further information, please contact:	
Benchmark Holdings plc	Tel:  0114 240 9939
Trond Williksen, CEO	
Septima Maguire, CFO	
Ivonne Cantu, Investor Relations	
	
	
Deutsche Numis (Nominated Adviser and Broker)	Tel:  020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah	
	
MHP	Tel:  020 3128 8004
Katie Hunt, Reg Hoare	benchmark@mhpgroup.com

 
Equity Development
Hannah Crowe	 
Tel:  020 7065 2692
	
 
About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is
to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition of
their stock - from broodstock and hatchery through to nursery and grow out.
Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com.